In this context, it is noteworthy that NLRP3 inhibition resulted in downregulation of CDK6 (Fig. 1a-c), as Uras et al. demonstrated that CDK6 serves as a transcriptional regulator of the FLT3 gene in AML cells [27]. This evidence concerns the gene CDK6 and acute myeloid leukemia.